₹1408.95
Overview of J B Chemicals & Pharmaceuticals Ltd
J B Chemicals & Pharmaceuticals Ltd's stock has surged over 50% in the last six months, following a stock split announcement. The company's Q1FY24 results also showed promising growth with an increase in revenue and profit.
Private Equity Firms Own 54% of J B Chemicals & Pharmaceuticals - 12 Sep, 2023
KKR & Co. Inc. is the largest shareholder of J B Chemicals & Pharmaceuticals with a 54% stake, giving them significant control over the company's future. Institutions account for 25%, insiders less than 1%, and the general public holds 21%.
CFO Resignation at JB Chemicals and Pharmaceuticals - 08 Sep, 2023
Lakshay Kataria, Chief Financial Officer of JB Chemicals and Pharmaceuticals, has resigned due to personal reasons. His resignation will be effective from November 30, 2023.
J B Chemicals & Pharmaceuticals Fixes Record Date for Stock Split - 31 Aug, 2023
J.B. Chemicals and Pharmaceuticals has fixed September 18, 2023, as the record date for a 1:2 stock split, with each share being subdivided into two equity shares with a face value of ₹ 1 each.
JB Pharma Gets Clearance from USFDA for Generic Version of Sinequan - 24 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd's subsidiary, JB Pharma, receives approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Doxepin Hydrochloride Capsules, allowing production of a generic version of Pfizer's Sinequan. Stock falls slightly due to technical pullback.
JB Chemicals Receives FDA Approval for Generic Drug - 23 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules, a generic version of Pfizer's Sinequan capsules used to treat mood disorders.
J B Chemicals & Pharmaceuticals CEO Divests Shares - 20 Aug, 2023
CEO Nikhil Chopra divested ₹40m worth of shares, reducing their holding by 50%. Insider selling leaves investors cautious despite the company's profitability and growth.
JB Chemicals & Pharmaceuticals Declares Dividend - 17 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd has declared a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set as August 17.
JB Chemicals & Pharmaceuticals Announces Dividend - 16 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd has announced a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set for August 17.
JB Chemicals & Pharmaceuticals Records Growth in Indian Pharma Market - 14 Aug, 2023
JB Chemicals and Pharmaceuticals saw a YoY growth of 8-11% in the Indian pharma market in July.
JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 10 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd reports a strong Q1 FY24 with a 35% YoY increase in net profit and 14% growth in revenue. Gross margins also expanded by 270 bps.
JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 09 Aug, 2023
JB Chemicals & Pharmaceuticals Ltd reported a 35% YoY increase in Q1FY24 net profit to Rs 142 crore and a 14% YoY growth in revenue to Rs 896 crore. Domestic formulations business grew 17%, while international business crossed the Rs 400 crore mark for the first time.
J B Chemicals & Pharmaceuticals Increases Dividend, But Caution Advised - 03 Aug, 2023
J. B. Chemicals & Pharmaceuticals has announced an increase in dividend to ₹9.25, but with negative free cash flows and unstable dividend history, it may not be a good income stock.
JB Chemicals & Pharmaceuticals Reports Strong Exports Growth and Trading at Lifetime High - 12 Jul, 2023
JB Chemicals & Pharmaceuticals Ltd reports strong export growth to the U.S. for Q1 FY24 and trades at a lifetime high after breaking above an upwards-tiled channel with a positive MACD crossover.
JB Chemicals hits 5-year high after Jefferies initiates buy rating - 21 Jun, 2023
JB Chemicals & Pharmaceuticals achieves 5-year high after Jefferies initiates buy rating. Robust product portfolio, strong R&D capabilities, and strategic acquisitions fuel growth.
JB Chemicals surges to record high on Jefferies' bullish view - 20 Jun, 2023
Jefferies assigns a buy rating and a price target of Rs 2,680 per share for JB Chemicals, expecting it to outperform industry growth.
Source: S&P Global Market Intelligence
0.56%
Downside
Day's Volatility:1.49%
Upside
0.92%
37.90%
Downside
52 Weeks Volatility:46.10%
Upside
8.20%
Returns % | |
1 Month Return | -3.65 % |
3 Month Return | 19.76 % |
1 Year Return | 48.84 % |
Market Stats | |
Previous Close | ₹1,411.30 |
Open | ₹1,418.40 |
Volume | 1.00L |
Market Cap | ₹21,864.99Cr |
Organisation | J B Chemicals & Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Fundamentals of J B Chemicals & Pharmaceuticals Ltd
Foreign Institutions have increased holdings from 8.63% to 9.54% in Jun 2023 quarter
In the last 3 years, JBCHEPHARM stock has moved up by 176.5%
Mutual Funds have decreased holdings from 16.17% to 15.57% in Jun 2023 quarter
Promoters have decreased holdings from 53.93% to 53.91% in Jun 2023 quarter
Netprofit is down for the last 3 quarters, 111.08 Cr → 87.63 Cr (in ₹), with an average decrease of 11.0% per quarter
Retail Investor have decreased holdings from 18.36% to 17.91% in Jun 2023 quarter
Revenue is down for the last 3 quarters, 810.78 Cr → 766.9 Cr (in ₹), with an average decrease of 2.7% per quarter
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Industry (47.44x)
September 26, 2023
Today (48.68x)
September 26, 2023
Highest (51.47x)
September 14, 2023
Funds | Holdings |
![]() | 0.93% |
![]() | 0.38% |
![]() | 1.9% |
Investors | Holdings % | Prev. 2 periods | 3M change |
---|---|---|---|
Promoter Holdings | 53.91% | ||
Foreign Institutions | 9.54% | 10.56 | |
Mutual Funds | 15.57% | ||
Retail Investors | 17.91% | ||
Others | 3.08% | 5.64 |
Technicals of J B Chemicals & Pharmaceuticals Ltd share
News & Events of J B Chemicals & Pharmaceuticals Ltd
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Price |
---|---|
52 Week High | ₹1524.5 |
52 Week Low | ₹875 |
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Returns |
---|---|
1 Day Returns | -2.35% |
1 Month Returns | -3.65% |
3 Month Returns | 19.76% |
1 Year Returns | 48.84% |